Custom Search

       

 

Dermpath-India

Pathology of Primary Cutaneous Diffuse Large B-Cell Lymphoma

Dr Sampurna Roy MD    

Dermatopathology Quiz Case 177

Diagnosis: Primary Cutaneous Diffuse Large B-Cell Lymphoma, leg type

 

                                                                                                                      

 

Syn: (According to WHO classification 2008 )- Primary Cutaneous Diffuse Large B-Cell Lymphoma, leg type

(According to WHO classification 2005 ) Primary cutaneous diffuse large B cell lymphoma, leg type and Primary Cutaneous Diffuse Large B-Cell Lymphoma, other.


Diffuse large B-cell lymphomas (DLBCL) are composed of variable proportions of centroblasts and centrocytes, although large cleaved, multilobulated and anaplastic cells may form part or all of the lesion. All cases of diffuse large B-cell lymphoma of the leg are included in this heading  (WHO classification 2005 and 2008).

The small number of cases reported as T-cell rich large B-cell lymphoma are also best included in this group as occurs at other sites.

Most cases of Crosti’s reticulohistocytoma of the dorsum probably also fall within this category although some may represent primary cutaneous marginal zone B-cell lymphoma or primary cutaneous follicular lymphoma.

Diffuse large B-cell lymphomas on the head and trunk and have an excellent prognosis despite their diffuse large cell morphology with radiotherapy being the treatment of choice.

On the other hand diffuse large B-cell lymphomas of the leg occur in a more elderly population with female predominance, have a much higher relapse rate and more unfavourable long term survival, chemotherapy is the optimum treatment.   

According to some pathologists, the behavior of a lymphoma is unlikely to be determined by whether it occurs above or below the waist.

They suggest that the poor prognosis of DLBCL of the leg is most likely related to the frequent presence of multiple lesions at presentation, and cite cases of DLBCL presenting with multiple lesions on the scalp and which have an equally aggressive clinical course.

Epstein-Barr virus is known to be associated with the development of lymphomas in immunosuppressed patients including diffuse large B-cell lymphoma.

Recently, age-related immune impairment was recognized as a predisposing factor in the development of Epstein-Barr virus-driven lymphoproliferative processes in elderly patients.

The proportion of EBV-related DLBCL cases in the elderly may be higher than that estimated at present.

Therefore, it was proposed by some authors that EBV expression should be assessed in primary cutaneous DLBCLs.

Clinical Features:

Primary Cutaneous Diffuse Large B-Cell Lymphoma arises on the trunks, head and neck and lower legs. The upper extremities seem to be rarely involved.

Most lesions present as tumours or papulonodules which may be surrounded by a slightly infiltrated erythematous halo, the later often preceding the development of the former.

Lesions on the upper body are frequently solitary or localised to a circumscribed area, where as those on the leg more often affect multiple discrete sites.

Despite a relatively high recurrence rate the prognosis is generally favourable with 5-year survival rates up to and in excess of 95% cases reported.

Radiotherapy is the treatment of choice for single/localized lesions on the head and trunk, whereas multiagent chemotherapy is preferred for multiple lesions at separate sites, whether or not these include the leg

Cases described as T-cell rich large B-cell lymphoma share the characteristic indolent behaviour of other Diffuse Large B-Cell Lymphoma limited to a single site.

Pathological Features: Dermatopathology Quiz Case 177

Most cases show a diffuse infiltrate extending from the upper dermis to subcutaneous fat, although early lesions may display a periadnexal and perivascular distribution superficially.

A grenz zone is usually present. 

The infiltrate usually has a polymorphic appearance comprising an admixture of centroblasts, immunoblasts and large centrocyte-like (cleaved) cells, the former characteristically forming the majority.

Cells with multilobulated nuclei and anaplastic cells may also be present in varying numbers.

Lesions occurring on the leg are said to often have a monotonous appearance, consisting almost entirely of large round cells, either centroblasts or immunoblasts.

Macrophages are often present but eosinophils, neutrophils and plasma cells are not commonly seen.

Small T-cells may be present in large numbers in some cases, accounting for reports of cutaneous T-cell rich large B-cell lymphoma.

Immunophenotype:

Immunohistochemical examination reveals that in all cases the neoplastic lymphocytes express CD20  and appear to lack CD5 and cyclin D1, although a significant proportion co-express CD10 and /or bcl-6. In a minority of cases CD43 and/or CD30 expression may be seen.

Bcl-2 positivity is seen in a variable number of cases. It has been proposed that bcl-2 expression is largely restricted to lesions occurring on the leg and that presence of the protein is associated with a poor prognosis.

Cases which can be reliably identified as possessing a diffuse large cell morphology in the literature uniformly lack t(14;18) when investigated by PCR, despite expression of CD10 or bcl-6.


Visit: Pathology of Subcutaneous Panniculitis-Like T-Cell Lymphoma

Visit: Pathology of Pagetoid reticulosis (Woringer-Kolopp disease)

Visit: Pathology of Primary Cutaneous Anaplastic Large Cell Lymphoma

Visit: Pathology of Cutaneous B-Lymphoblastic Lymphoma

Visit: Pathology of Intravascular Large B-cell Lymphoma

Visit: Pathology of Primary Cutaneous Marginal Zone B-Cell Lymphoma

Visit: Pathology of Lymphomatoid Papulosis - Cells resembling 'chunks of coal'

Further reading:

Cutaneous B-cell lymphoma.

Can cutaneous low-grade B-cell lymphoma transform into primary cutaneous diffuse large B-cell lymphoma? An immunohistochemical study of 82 cases.

Epstein-barr virus-positive primary cutaneous diffuse large B-cell lymphoma in an immunocompetent patient.

Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France.

Diffuse large B-cell lymphoma.

Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.

Primary cutaneous diffuse large B-cell lymphoma leg type presenting with hemophagocytic syndrome.

Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations.

Diffuse large B-cell lymphoma presenting as a chronic leg ulcer: the importance of repeat tissue biopsy.

The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases.

[An atypical presentation of primary cutaneous diffuse B-cell lymphoma, leg type].

 

 

Dr Sampurna Roy  MD

Consultant  Histopathologist (Kolkata - India)


 

 

Histopathology-India.net

 

Pathopedia-India.com

 

Surgical Pathology.com

 

Pathology-India.com

 

Dermpath-India

 

Infectious Disease Online

 

Pathology Quiz Online 

 

Paediatric Pathology Online

 

Pancreatic Pathology Online

 

Paraganglioma-Online

 

Endocrine Pathology Online

 

Eye Pathology Online

 

Ear Pathology Online

 

Cardiac Path Online

 

Pulmonary Pathology Online

 

Lung Tumour Online

 

Mesothelioma-Online

 

Nutritional Pathology Online

 

Environmental Pathology Online

 

Soft Tissue Tumour Online

 

GI Path Online-India

 

Gallbladder Pathology Online

 

E-book - History of Medicine  

 

Microscope - Seeing the Unseen

 

 roypath.in

 

 

Disclaimer

Privacy Policy  

Advertising Policy

Copyright © 2017  histopathology-india.net